Zdrowie i gospodarka · 17/08/2026

FDA Requests Public Comment on Proposed IND Application Requirements

The Food and Drug Administration (FDA) is requesting public comment on a proposed collection of information related to Investigational New Drug (IND) applications, which must be submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.